| 21st Oct 2022 7:00 am |
RNS |
Upcoming events participation |
| 6th Oct 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 6th Oct 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 6th Oct 2022 7:00 am |
RNS |
CEO Share Purchase |
| 4th Oct 2022 7:00 am |
RNS |
POLB 001 US Patent update |
| 21st Sep 2022 7:00 am |
RNS |
Poolbeg licence of Melioidosis vaccine candidate |
| 12th Sep 2022 7:00 am |
RNS |
HC Wainwright Global Investment Conference |
| 6th Sep 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 6th Sep 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 6th Sep 2022 7:00 am |
RNS |
Interim Results |
| 31st Aug 2022 7:25 am |
RNS |
Notice of Results |
| 29th Jul 2022 7:00 am |
RNS |
Appointment of Joint Broker |
| 20th Jul 2022 7:00 am |
RNS |
POLB001 human challenge clinical trial to commence |
| 12th Jul 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 12th Jul 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 27th Jun 2022 7:00 am |
RNS |
Project update for AI model of RSV data |
| 21st Jun 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 21st Jun 2022 4:36 pm |
RNS |
Price Monitoring Extension |
| 26th May 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 26th May 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 26th May 2022 7:00 am |
RNS |
US patents granted for POLB 001 and POLB 002 |
| 25th May 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 25th May 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 23rd May 2022 1:01 pm |
RNS |
TR-1: Notification of major interest in shares |
| 12th May 2022 7:00 am |
RNS |
GMP manufacturing contract signed |
| 11th May 2022 7:00 am |
RNS |
Attendance at European Melioidosis Congress |
| 27th Apr 2022 7:00 am |
RNS |
Distribution in Specie update |
| 14th Apr 2022 7:00 am |
RNS |
Key POLB 002 European Patent Granted |
| 11th Apr 2022 7:00 am |
RNS |
Distribution in Specie Shareholders |
| 4th Apr 2022 12:26 pm |
RNS |
Result of AGM |
| 31st Mar 2022 7:00 am |
RNS |
POLB001 Update - Clinical Trial Agreement Signed |
| 30th Mar 2022 7:00 am |
RNS |
Commencement of trading on US OTCQB market |
| 24th Mar 2022 7:00 am |
RNS |
AI deal signed with CytoReason |
| 9th Mar 2022 7:00 am |
RNS |
Notice of AGM |
| 3rd Mar 2022 7:00 am |
RNS |
Final Results |
| 28th Feb 2022 7:00 am |
RNS |
Notice of Results |
| 24th Feb 2022 7:00 am |
RNS |
Artificial Intelligence deal with OneThree Biotech |
| 31st Jan 2022 7:00 am |
RNS |
Confirmation of vaccine platform licence execution |
| 17th Jan 2022 7:00 am |
RNS |
Exclusive license of RNA-based immunotherapy asset |
| 16th Dec 2021 7:00 am |
RNS |
Poolbeg to develop oral vaccine delivery platform |
